Rocket Pharmaceuticals Inc (RCKT)
$13.37 $0.01 (0.07%) 4:38 PM 12/11/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$1.27B -
Day's Range
$12.83 - $15.00 -
Volume
1,187,070 -
52 Week Low / High
$12.62 - $32.52 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
RCKT's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 11
- Strong Buy
- 4
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $50.00
- Target Price
Company News
-
Rocket Pharmaceuticals Announces Completion of Enrollment in Phase 2 Pivotal Trial of RP-A501 for the Treatment of Danon Disease — Sep 17th, 2024
CRANBURY, N.J., September 17, 2024--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that all patients have been ...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$